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Multiple sclerosis (MS) is a partially heritable autoimmune disease. 
HLA-DR2 is the largest identified genetic risk factor for MS. The 
largest identified genetic risk factor is haplotype from the MHC 
class II HLA-DR2, which increases the disease risk. The HLA-DR2 
distribution in MS patients has been confirmed, but contradictory 
outcomes have been found. Moreover, the HLA-DR2 effect on 
ethnicity and gender is unclear. There are no data regarding the HLA-
DR2 (HLA-DRB1*1501-DRB5*01-DQB1*0602) association with 
MS in Khuzestan Province, Iran. This study aimed to investigate the 
association of HLA-DR2 with MS regarding both sex and ethnicity 
in this province.
Materials & Methods
A total of 399 individuals were recruited. HLA typing was conducted 
using the polymerase chain reaction amplification with sequence-
specific primers technology. The HLA-DR2 association with MS was 
analyzed, and also its probable association with gender, ethnicity, the 
expanded disability status scale (EDSS), and MS clinical course was 
examined using the Chi-square test.
Results
HLA-DRB5*01--DQB1*0602- as the most common HLA haplotype 
was found in both patient and control groups. In contrast, the 
DRB5*01+-DRB1*1501+-DQB1*0602- frequency was very low in 
the groups. It was observed that haplotypes had no association with 
MS susceptibility. Most of the haplotypes showed no association with 
ethnicity, sex, EDSS, and MS course except for the HLA-DRB5*01+-
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DRB1*1501+-DQB1*0602- haplotype that was positively associated 
with EDSS steps 5 to 10 (p=0.014) and non-RRMS (p=0.023).
Conclusion
There was no association between HLA-DR2 and MS susceptibility. 
However, the higher HLA-DRB5*01+-DRB1*1501+-DQB1*0602- 
frequency may play a role in MS development. Also, HLA-DR2 did 
not increase significantly concerning clinical course, ethnicity, sex, 
and EDSS. This study further supports the importance of replication 
studies as susceptible loci that might differ in various ethnicities. 
Therefore, it is concluded that the association between HLA-DR2 
and MS is more allelic than haplotypic in Khuzestan.




Autoimmune diseases refer to a group of complex 
disorders caused by the loss of immunologic 
tolerance to self-antigens that lead to the immune-
mediated destruction of organs and tissues. 
Autoimmune diseases affect up to about 5% of the 
world population. These diseases constitute several 
complex disorders, such as multiple sclerosis 
(MS), characterized by demyelination with axonal 
and neuronal degeneration (1, 2). The incidence of 
MS is increasing. It affects women more frequently 
than men and most often starts between 20 and 40 
years of age (3). MS manifestations include various 
neurological dysfunctions, like visual and sensory 
problems, limb weakness, or gait disturbance. 
Four classical subtypes of MS include relapsing-
remitting MS (RRMS), secondary progressive 
MS (SPMS), primary progressive MS (PPMS), 
and primary relapsing MS (PRMS). However, 
in 85% of cases, there is a clinically isolated 
syndrome (CIS) that later converts to RRMS (4). 
Studies on MS pathogenesis have indicated that an 
autoimmune mechanism mediated by B cells and 
the innate immune system has essential roles (5).
Epidemiological surveys have consistently 
shown that the MS frequency varies significantly 
worldwide. The pathogenesis and etiology of this 
disease are still unknown, although susceptibility 
to the disease depends on a complex interaction 
between environment and genetic factors (3). 
Studies on twins, adoptees, and migrants suggest 
that familial clustering is determined mainly 
by genetic factors. However, MS susceptibility 
is thought to be conferred by both genetic and 
environmental factors (3).
MS risk increases from typically 1 in 1,000 in the 
normal population to 1 in 4 or so for identical twins 
where one twin has MS. Much of this heritability is 
now explained and is due almost entirely to genes 
affecting the immune response. Over 200 genes 
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have now been identified and, of these, 13 MHC 
loci and 110 non-MHC genetic loci have been 
detailed (6).
The human leucocyte antigen gene (HLA) is 
subdivided into three classes: I, II, and III. 
Classical alpha and beta chain genes, including DP, 
DQ, and DR, are located in the class II region (7). 
Associations of MS with alleles in HLAs have been 
identified for several decades. However, it is not 
yet fully understood how exactly they alter the risk 
of developing MS and the pathogenic mechanism 
(8). Associations of DRB1*1501 with MS have 
been consistently proven in most populations 
tested, although the allele does not fully explain the 
MS association. More studies based on genome-
wide association studies have been performed 
for autoimmune diseases such as MS and have 
recognized specific HLA-DR/DQ genes. However, 
the remarkably intense linkage disequilibrium 
(LD) across the HLA region has prevented the 
unequivocal ascertainment of the primary disease-
risk HLA gene. The class II association has 
been mapped to the DRB5*0101- DRB1*1501-
DQA1*0102- DQB1*0602 haplotype in the 
North European population (9). These variants are 
almost always present together in the Caucasian 
population, and it is impossible to distinguish the 
primary association. It has been found that the 
robust LD mechanism in HLA genes is consistent 
with a functional epistatic interaction between 
DRB5*0101 and DRB1*1501 alleles. Moreover, 
functional epistasis is associated with a milder form 
of experimental autoimmune encephalomyelitis 
in mice 10. It appears that HLA-DRB1*1501, 
HLA-DQB1*0602, and HLA-DQA1*0102 are 
considered as the most critical factors, particularly 
in MS susceptibility (11).
The crystal structure of HLA-DR2 complexed 
with a peptide from a human myelin basic protein 
shows that HLA proteins have various structural 
properties for presenting antigens based on their 
amino acid sequence. The HLA association with 
MS has supported the notion that MS pathogenesis 
is due to an autoimmune reaction, which may be 
against myelin-related antigens in the restricting 
context of DRB1*1501 (12).
The expanded disability status scale (EDSS) 
quantifies the MS disability level and monitors 
changes in the disability over time. John Kurtzke 
developed the scale in 1983. EDSS steps 1.0 to 
4.5 refer to patients who can walk without any aid. 
EDSS steps 5.0 to 9.5 explain walking impairment, 
and death due to MS is defined by the EDSS step 
10 (13). 
Pharmacogenetics refers to the study of inherited 
genetic variants, which can affect individual 
responses to drugs in terms of therapeutic and 
adverse effects. HLA is the most polymorphic gene 
in humans, and the heterogeneity carriage of HLA-
DR2 in MS patients reinforces the fact that MS 
pharmacotherapy can be targeted to specific steps 
in the pathogenesis pathway. Hence, identifying 
genetic varieties in MS patients can be of great 
importance. Moreover, the study of MS genetic 
susceptibility using the HLA ethnicity association 
calls attention to potential pharmacotherapy 
implications presented by mixed populations. 
Geographic regions and ethnicities may affect 
MS immunogenetics. Due to diverse ethnicities in 
Khuzestan in the southwest of Iran, where Iranian 
Arabs are mostly located, and since there are a few 
studies on this issue in Arabic countries, this study 
can be of great importance.
Here, we integrated genotypes of HLA alleles for 
the DRB5, DRB1, and DQB1 genes concerning 
MS-associated variants to determine the role of 
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putative haplotypes that alter MS susceptibility. 
We also analyzed the association of the HLA-DR2 
haplotype with gender, MS type, ethnicity, and the 
EDSS of MS patients in Khuzestan Province.
Materials & Methods
A cohort comprising 198 patients and 201 healthy 
controls, matched by geographic region, age, and 
gender, was used in the study. The population 
was composed of a case-control set of Arab and 
non-Arab populations in Khuzestan Province, 
Southwest Iran.
MS Patients
A total of 198 MS patients, including 154 women, 
41 men, and three people with unknown gender, 
were diagnosed according to the revised McDonald 
criteria (14). Women were more likely than men 
to develop MS. Written informed consent was 
obtained from each patient before enrolling in the 
study. Detailed information, such as age, gender, 
ethnicity, positive family history, and clinical 
features, were provided from the Khuzestan MS 
Society patients, Ahvaz, Iran. A neurologist carried 
out clinical parameters estimation and EDSS 
scoring. The MS patients were divided into two 
groups regarding EDSS, including a scale of 0 (no 
disability) to 5 (more severe disability) and 5 to 
10 (death due to MS). Moreover, the patients were 
stratified into RRMS as the most common disease 
course and non-RRMS groups.
Control Group
The study included 201 healthy individuals, of 
whom 125 were women, 41 were men, and 35 had 
unknown gender. The participants were selected 
from the Shafa Hospital (Ahvaz, Iran). The control 
participants were also informed about the study and 
completed a questionnaire on ethnicity, sex, age, 
and positive family history of autoimmune disease. 
The healthy individuals had no family history of 
autoimmune disease.
Genotyping
Whole blood was collected in ethylene diamine 
tetraacetic acid (EDTA) tubes. The extracted DNA 
was isolated using the standard salting-out protocol. 
The quality and quantity of genomic DNA were 
determined by agarose gel electrophoresis and 
NanoDrop; thus, several random genome DNAs 
were selected.
DNA was stored at -20°C until analysis. HLA 
typing was performed using the polymerase chain 
reaction amplification with sequence-specific 
primers (PCR-SSP) technique and repeated if 
discordant data were achieved. A set of genotypes 
was randomly analyzed using direct DNA 
sequencing.
The IMGT/HLA database (http://www.ebi.ac.uk/) 
was used for primer design. The primers were 
aligned in NCBI/blast (www.ncbi.nlm.nih.gov). 
The HLA-DQB1*0602, -DRBI*1501, -DRB5*01 
primers used for genotyping were published 
previously (15-17).
Since specific PCR-SSP products assign alleles, 
the polymerase chain reaction (PCR) product size 
can help interpret the data.
Every PCR reaction is assumed to work if 
the internal control is amplified. The myelin 
oligodendrocyte glycoprotein (MOG) gene was 
used for this goal. Thus, in ideal PCR conditions, a 
356 bp band must be observed. The MOG primers 
were designed by the web primer design program, 
batchprimer3, accessible at (http://probes.pw.usda.
gov/batchprimer3/). They were also aligned in 
NCBI/blast. The MOG primers were published 
elsewhere (15-17).
PCR was conducted in a total volume of 25 μl 
containing 100-200 ng of genomic DNA, 12.5 
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μl master mix, 1 μl of each primer (10 μM), 2 μl 
dNTP (5 mM), and 8.5 μl water.
Agarose gel electrophoresis was used to determine 
the amplified products. Thus, 3 to 5 μl of PCR 
products were run on 1.5% agarose gel to observe 
the target band. All the analyses were performed 
in the Genetic Laboratory of the Shahid Chamran 
University of Ahwaz (Ahvaz, Iran).
Statistical Analysis
The frequency of HLA-DRB1*1501, -DRB5*01, 
and -DQB1*0602 alleles were published 
previously 15-17. The allele frequency of three 
allelic DR2 haplotypes, including DRB5*01-
-DRB1*1501+- DQB1*0602+, DRB5*01+ 
-DRB1*1501+ -DQB1*0602-, and DRB5*01+-
DRB1*1501+-DQB1*0602+, as well as DR2 
haplotypes, including DRB5*01+-DQB1*0602-, 
DRB5*01--DQB1*0602-, DRB5*01+-
DQB1*0602+, and DRB5*01--DQB1*0602+, 
were determined as a percentage. Fisher’s exact 
and Chi-square tests were used to compare the 
frequency of the mentioned genotypes between 
the patients and controls. SPSS statistical software 
(version 16, SPSS, SPSS Inc., USA) was used for 
data analysis. A p-value < 0.05 was considered 
significant.
Results
As mentioned above, the HLA-DR2 haplotype 
was evaluated among the 198 MS patients and 
201 healthy age- and sex-matched individuals.
The summarized characteristics of the MS 
patients were published previously (15-17). 






DQB1*0602+, and DRB5*01--DQB1*0602+, 
were investigated in the MS patients and 
compared with the healthy controls (Table 1). 
DRB5*01--DQB1*0602- was the most frequent 
variant between the patients and controls. 
However, no significant difference was found 
concerning the mentioned haplotypes between 
the two groups (39.26% vs. 36.31% p = 0.547). It 
should be noted that the frequency of DRB5*01+-
DRB1*1501+-DQB1*0602- was also low in both 
patients and controls (0%).
Moreover, no significant correlation was observed 
among the mentioned variants with Fars and Arab 
ethnics (Table 2 and 3). It was found that no one 
carried DRB5*01+-DRB1*1501+-DQB1*0602- 
and DRB5*01+-DQB1*0602- haplotypes in 
controls (0%).
Furthermore, the HLA-DRB5*01+-DRB1*1501+-
DQB1*0602- haplotype was positively associated 
with EDSS steps 5 to 10 (12.5% vs. 1.15%, p= 
0.014), although no more association was found 
between the rest of the haplotypes and level of 
disability, as shown in Table 4.
As shown in Table 5, the mentioned variants 
demonstrated no significant correlation with 
RRMS as the most common disease course except 
for DRB5*01+-DRB1*1501+-DQB1*0602- that 
showed a positive association with non-RRMS 
(11.11% vs. 1.16%, p = 0.023).
We also studied the association of HLA-DR2 
haplotypes with MS in the females and males 
separately. There was no association between 
genotype frequencies of these haplotypes with 
gender. It was found that no male MS patient 
carried the DRB5*01+-DRB1*1501+-DQB1*0602- 
and DRB5*01+-DQB1*0602- haplotypes.
40
Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) 
Iran J Child Neurol. Summer 2021 Vol. 15 No. 3
Table 1. Association of DR2 haplotype with MS in Khuzestan province






1 DRB5*01+-DQB1*0602- 6 (3.27) 183 4 (2.08) 192 0.452
2 DRB5*01--DQB1*0602- 75 (39.26) 191 73 (36.31) 201 0.547
3 DRB5*01+-DQB1*0602+ 44 (23.78) 185 34 (18.27) 186 0.184
4 DRB5*01--DQB1*0602+ 62 (33.87) 183 68 (35.23) 193 0.738
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 21 (10.79) 195 17 (10.30) 165 0.886
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 3 (1.51) 198 0 (0) 174 0.103
7 DRB5*01--DRB1*1501+- DQB1*0602+ 26 (13.54) 192 14 (8.18) 171 0.104
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Table 2. Association of DR2 haplotype with Fars ethnic in MS patients of Khuzestan province






1 DRB5*01+-DQB1*0602- 6 (5.08) 115 2 (2.53) 79 0.355
2 DRB5*01--DQB1*0602- 39 (33.91) 115 26 (32.09) 81 0.790
3 DRB5*01+-DQB1*0602+ 29 (25) 116 11 (15.71) 70 0.135
4 DRB5*01--DQB1*0602+ 40 (34.78) 115 33 (42.85) 77 0.259
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 12 (10.71) 112 6 (7.69) 78 0.484
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 2 (1.62) 123 0 (0) 79 0.255
7 DRB5*01--DRB1*1501+- DQB1*0602+ 16 (13.11) 122 5 (7.46) 67 0.273
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Table 3. Association of DR2 haplotype with Arab ethnic in MS patients of Khuzestan province






1 DRB5*01+-DQB1*0602- 1 (1.40) 71 0 (0) 88 0.267
2 DRB5*01--DQB1*0602- 32 (44.44) 72 34 (40.96) 83 0.662
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3 DRB5*01+-DQB1*0602+ 14 (20.58) 68 15 (19.73) 76 0.899
4 DRB5*01--DQB1*0602+ 23 (33.33) 69 28 (35) 80 0.831
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 7 (9.72) 72 9 (10.84) 83 0.819
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 1 (1.25) 80 0 (0) 89 0.290
7 DRB5*01--DRB1*1501+- DQB1*0602+ 9 (12) 75 8 (22.85) 35 0.142
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Table 4. Association of HLA DR2 with EDSS in MS patients of Khuzestan province.






1 DRB5*01+-DQB1*0602- 5 (3.10) 161 1 (14.28) 7 0.119
2 DRB5*01--DQB1*0602- 55 (34.59) 159 5 (62.05) 8 0.108
3 DRB5*01+-DQB1*0602+ 41 (25.78) 159 0 (0) 8 0.098
4 DRB5*01--DQB1*0602+ 55 (34.37) 160 2 (25) 8 0.585
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 19 (10.79) 176 0 () 8 0.326
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 2 (1.15) 173 1 (12.5) 8 0.014*
7 DRB5*01--DRB1*1501+- DQB1*0602+ 25 (15.06) 166 2 (25) 8 0.448
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Table 5. Analysis of association between HLA haplotypes and RRMS.






1 DRB5*01+-DQB1*0602- 5 (3.10) 161 1 (11.11) 9 0.205
2 DRB5*01--DQB1*0602- 65 (3.86) 168 3 (33.33) 9 0.748
3 DRB5*01+-DQB1*0602+ 40 (24.53) 163 1 (11.11) 9 0.357
4 DRB5*01--DQB1*0602+ 56 (34.78) 161 4 (44.44) 9 0.555
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 20 (11.56) 173 0 (0) 9 0.280
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 2 (1.16) 172 1 (11.11) 9 0.023*
7 DRB5*01--DRB1*1501+- DQB1*0602+ 25 (14.88) 168 2 (22.22) 9 0.551
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
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Table 6. Association of HLA haplotype with female in MS patients of Khuzestan province






1 DRB5*01+-DQB1*0602- 6 (4.20) 149 2 (20.06) 97 0.396
2 DRB5*01--DQB1*0602- 53 (39.84) 133 36(33.96) 106 0.350
3 DRB5*01+-DQB1*0602+ 35 (23.80) 147 18 (14.47) 103 0.228
4 DRB5*01--DQB1*0602+ 48 (32.65) 147 43 (40.95) 105 0.176
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 14 (9.79) 143 13 (10.40) 125 0.869
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 3 (1.94) 154 0 (0) 107 0.146
7 DRB5*01--DRB1*1501+- DQB1*0602+ 18 (12.16) 148 7 (7.52) 93 0.251
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Table 7. Association of HLA haplotype with male in MS patients of Khuzestan province






1 DRB5*01+-DQB1*0602- 0 (0) 40 1 (3.03) 33 0.268
2 DRB5*01--DQB1*0602- 17 (41.46) 41 15 (36.58) 41 0.651
3 DRB5*01+-DQB1*0602+ 8 (21.05) 38 6 (17.14) 35 0.672
4 DRB5*01--DQB1*0602+ 14 (35.89) 39 12 (34.28) 35 0.885
5 DRB5*01+-DRB1*1501+-DQB1*0602+ 4 (10.52) 38 1 (2.50) 40 0.077
6 DRB5*01+ -DRB1*1501+ -DQB1*0602- 0 (0) 39 0 (0) 40 -
7 DRB5*01--DRB1*1501+- DQB1*0602+ 8 (20) 40 5 (15.62) 32 0.632
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).
Discussion 
MS is a complex neurodegenerative and 
multifactorial disease. The exact cause of the 
disease is still unclear, but it probably results 
from the interaction of genetic, epigenetic, and 
environmental factors and intrinsic factors, and 
epistatic effects (e.g., gene-gene interactions). The 
findings implicate that DRB5*01--DQB1*0602- 
usually has a high frequency in the studied 
population, while DRB5*01+-DRB1*1501+-
DQB1*0602- and DRB5*01+-DQB1*0602- are 
rare in Khuzestan, in both sex and ethnic groups. 
Thus, frequency differences between the studied 
groups are not meaningful. 
43
Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) 
Iran J Child Neurol. Summer 2021 Vol. 15 No. 3
The present study aimed to evaluate the 





DQB1*0602-, DRB5*01+-DQB1*0602+, and 
DRB5*01--DQB1*0602+ haplotypes and to 
assess the effect of the HLA-DR2 haplotype on 
MS susceptibility in Khuzestan Province. Since 
no association was found between the HLA-
DR2 variants and MS susceptibility, most of 
the mentioned haplotypes had low frequency 
in Southwest Iran. It was concluded that these 
haplotypes might not affect the MS development. 
However, MS is a complex, heterogenic, 
multifactorial disease with an unknown etiology. 
Thus, other factors like recombination, genetic 
drift, latitude, epistasis, and founder effect might 
affect the MS pathogenesis.
Subsequently, numerous studies have been 
conducted on the association between HLA 
antigens and MS. In several studies, the role 
of the HLA class II, especially DQA1*0102, 
DQB1*0602, DRB1*1501, and DRB5*01, has 
been hypothesized to be the primary HLA genetic 
susceptibility factor for MS susceptibility 4,17. 
A study on many Swedish MS patients showed 
that the HLA-DR2 haplotype was overrepresented 
among the patients (18).
On the other hand, association studies in 
some populations have confirmed that 
the DRB1*1501 allele itself determines MS-
associated susceptibility (19). While in other 
populations, there are various risk variants, or 
they do not contain only the DRB1*1501 allele; 
as in the Sardinia population where MS was 
correlated with the HLA-DRB1 * 0405-
DQA1 *0501-DQB1*0301 and HLA-DRB1* 
0301-DQA1*0501-DQB1*0201 haplotypes 
(20). A partial explanation for strong linkage 
disequilibrium in the HLA was provided by 
epistasis among the HLA class II (DRB1, DQA1, 
and DQB1) alleles in human immune responses. 
It has relevance to animal models, as well. Also, 
DRB1, DQA1, and DQB1 alleles contribute to 
MS susceptibility, although epistatic interactions 
suggest haplotypic rather than allelic HLA 
association (21). 
The association of MS with the HLA-
DRB1*1501-DQB1*0602 haplotype was 
repeatedly demonstrated in high-risk northern 
European populations. It is unclear whether the 
effect is explained by the HLA-DQB1 or -DRB1 
gene within the susceptibility haplotype, which 
are in strong LD. African American family-
based and case-control association studies on 
MS revealed that a primary role for the DRB1 
locus was independent of DQB1*0602. Thus, it 
was unlikely to be solely explained by admixture 
since a substantial proportion of the susceptibility 
chromosomes from African American patients 
with MS displayed haplotypes consistent with an 
African origin (22).
HLA-DQB1*0602 determined MS susceptibility 
in a humanized MS model in HLA-DRB1*1501; 
-DQB1*0602 transgenic mice. A recent work in 
humanized mice indicated functional epistatic 
interactions whereby DRB5*0101 directly 
modulates the severity of the ensuing disease 
through the activation-induced cell death of 
encephalitogenic T cells, which are restricted 
by DRB1*1501. The HLA-DR15 haplotype 
(DRB1*1501, DRB5*0101, and DQB1*0602) 
has been identified as the most substantial 
susceptibility factor for MS (20). On the contrary, 
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no correlation was found in the current study 
between HLA-DRB1*1501, -DRB5*0101, and 
-DQB1*0602 with MS.
A study on Afro-Brazilians showed that 
DQB1*0602 was associated with the disease 
in the absence of the DRB1*1501 allele 
(21). However, no association was observed 
between MS with carrying DRB1*1501 and 
DQB1*0602 in our survey. As in studies on the 
current population, the positive association of 
DRB1*1501 allele and the lack of DQB1*0602 
association with MS were found in Khuzestan 
Province (15, 16). Thus, it is likely that the 
association with the disease is more allelic than 
haplotypic in these ethnic groups. 
Contrary to this study, an HLA-DR2-related haplotype 
implicated that the HLA-DRB1*1501-DRB5*01-
DQB1*0602-DQA1*0102 haplotype was susceptible to 
MS (22).
This study aimed to examine part of MS genetic 
background in Khuzestan Province. In the present 
study, no association was observed between the 
MS patients and healthy controls regarding the 
HLA-DR2-related haplotype. Thus, it is thought 
that MS is more allelic than haplotypic. It should be 
noted that as MS is a polygenic disease, some other 
haplotypes in other genes probably are associated 
with MS susceptibility. The differences observed 
between our results and other populations could 
be due to discrepancies in the genetic pool of the 
populations, latitude, and environmental factors. A 
small sample size may affect the statistical power. 
Therefore, our data need confirmation in larger 
sample size assays.
On the other hand, the population of Khuzestan 
Province is heterogeneous and consists of various 
ethnicities like Lor, Arab, Kord, and Fars. Additional 
polymorphisms exist in the HLA gene that might 
contribute to the susceptibility or activity of MS 
in this population. A larger number of patients and 
control subjects are required to verify the results. 
In conclusion, this study supports the importance 
of replication studies as susceptible loci that might 
differ in various ethnic groups. It is suggested to 
type more haplotypes in other MS populations, 
especially in regions considered high risk for MS, 
to achieve more documented data.
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